Oncternal Therapeutics, Inc. (ONCT)
NASDAQ: ONCT · Real-Time Price · USD
1.700
+0.050 (3.03%)
Sep 19, 2024, 4:00 PM EDT - Market closed
Oncternal Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
Cash & Equivalents | 6.38 | 6.7 | 37.14 | 90.77 | 116.74 | 20.05 | Upgrade
|
Short-Term Investments | 15.05 | 27.56 | 26.58 | - | - | - | Upgrade
|
Cash & Short-Term Investments | 21.43 | 34.26 | 63.72 | 90.77 | 116.74 | 20.05 | Upgrade
|
Cash Growth | -52.91% | -46.24% | -29.79% | -22.25% | 482.20% | -2.88% | Upgrade
|
Accounts Receivable | 0.38 | 0.49 | 0.18 | 0.59 | - | - | Upgrade
|
Other Receivables | 0.18 | 0.14 | - | 0.36 | - | - | Upgrade
|
Receivables | 0.56 | 0.63 | 0.18 | 0.94 | - | - | Upgrade
|
Prepaid Expenses | 1.27 | 1.17 | 3.39 | 1.14 | 1.27 | 0.74 | Upgrade
|
Total Current Assets | 23.26 | 36.06 | 67.29 | 92.85 | 118 | 20.79 | Upgrade
|
Property, Plant & Equipment | 0.19 | 0.26 | 0.09 | 0.08 | 0.04 | 0.19 | Upgrade
|
Other Long-Term Assets | 0.41 | 0.41 | 1.27 | 0.66 | 0.77 | 0.77 | Upgrade
|
Total Assets | 23.86 | 36.73 | 68.65 | 93.59 | 118.81 | 21.74 | Upgrade
|
Accounts Payable | 1.9 | 1.15 | 2.92 | 1.96 | 1.14 | 0.87 | Upgrade
|
Accrued Expenses | 5.97 | 3.88 | 4.68 | 3.43 | 3.03 | 2.71 | Upgrade
|
Current Portion of Leases | 0.19 | 0.17 | 0.09 | 0.08 | 0.04 | 0.1 | Upgrade
|
Current Unearned Revenue | - | - | - | - | 1.63 | 3.64 | Upgrade
|
Other Current Liabilities | - | - | - | - | 0.01 | 0.02 | Upgrade
|
Total Current Liabilities | 8.06 | 5.2 | 7.68 | 5.47 | 5.86 | 7.34 | Upgrade
|
Long-Term Leases | 0.05 | 0.15 | - | - | - | 0.09 | Upgrade
|
Other Long-Term Liabilities | - | 1.33 | - | - | - | - | Upgrade
|
Total Liabilities | 8.11 | 6.68 | 7.68 | 5.47 | 5.86 | 7.43 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0.05 | 0.05 | 0.02 | Upgrade
|
Additional Paid-In Capital | 230.48 | 227.83 | 219.26 | 202.2 | 195.7 | 79.87 | Upgrade
|
Retained Earnings | -214.73 | -197.78 | -158.3 | -114.13 | -82.8 | -65.57 | Upgrade
|
Comprensive Income & Other | -0 | 0 | 0.01 | - | - | - | Upgrade
|
Total Common Equity | 15.75 | 30.05 | 60.97 | 88.12 | 112.95 | 14.31 | Upgrade
|
Shareholders' Equity | 15.75 | 30.05 | 60.97 | 88.12 | 112.95 | 14.31 | Upgrade
|
Total Liabilities & Equity | 23.86 | 36.73 | 68.65 | 93.59 | 118.81 | 21.74 | Upgrade
|
Total Debt | 0.24 | 0.32 | 0.09 | 0.08 | 0.04 | 0.19 | Upgrade
|
Net Cash (Debt) | 21.19 | 33.94 | 63.64 | 90.69 | 116.7 | 19.86 | Upgrade
|
Net Cash Growth | -53.05% | -46.67% | -29.83% | -22.29% | 487.57% | -3.80% | Upgrade
|
Net Cash Per Share | 7.17 | 11.54 | 24.20 | 36.78 | 114.94 | 38.46 | Upgrade
|
Filing Date Shares Outstanding | 2.96 | 2.96 | 2.94 | 2.47 | 2.46 | 0.77 | Upgrade
|
Total Common Shares Outstanding | 2.96 | 2.95 | 2.87 | 2.47 | 2.44 | 0.77 | Upgrade
|
Working Capital | 15.2 | 30.86 | 59.61 | 87.39 | 112.15 | 13.45 | Upgrade
|
Book Value Per Share | 5.32 | 10.19 | 21.22 | 35.66 | 46.29 | 18.60 | Upgrade
|
Tangible Book Value | 15.75 | 30.05 | 60.97 | 88.12 | 112.95 | 14.31 | Upgrade
|
Tangible Book Value Per Share | 5.32 | 10.19 | 21.22 | 35.66 | 46.29 | 18.60 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.